Shoubo Yang

No. 119, South Fourth Ring West Road
Fengtai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Advances in diagnosis and treatment of intracranial germ cell tumors and future directions.

Advances in diagnosis and treatment of intracranial germ cell tumors and future directions.

Journal: Critical reviews in oncology/hematology

Published: April 01, 2026

Role of CSF interleukin-6 in the prognosis of patients with Leptomeningeal metastases of glioblastoma.

Role of CSF interleukin-6 in the prognosis of patients with Leptomeningeal metastases of glioblastoma.

Journal: Discover oncology

Published: January 05, 2026

Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.

Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.

Journal: CNS neuroscience & therapeutics

Published: August 06, 2025

Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system.

Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system.

Journal: Leukemia & lymphoma

Published: January 17, 2025

The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma.

The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma.

Journal: Journal of inflammation research

Published: May 06, 2024

Primary brainstem lymphoma: clinical characteristics, treatment methods, and prognostic factors of 56 patients.

Primary brainstem lymphoma: clinical characteristics, treatment methods, and prognostic factors of 56 patients.

Journal: The oncologist

Published: May 06, 2024

Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.

Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.

Journal: Journal of neuro-oncology

Published: February 20, 2024

Zanubrutinib delays selinexor resistance evolution in biopsy sample-derived primary central nervous system lymphoma models.

Zanubrutinib delays selinexor resistance evolution in biopsy sample-derived primary central nervous system lymphoma models.

Journal: iScience

Published: December 04, 2023

Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.

Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.

Journal: Journal of cancer research and therapeutics

Published: September 13, 2023

Association between dietary minerals and glioma: A case-control study based on Chinese population.

Association between dietary minerals and glioma: A case-control study based on Chinese population.

Journal: Frontiers in nutrition

Published: December 08, 2022

Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis via an ommaya reservoir.

Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis via an ommaya reservoir.

Journal: Frontiers in oncology

Published: October 03, 2022

Is extremely low frequency pulsed electromagnetic fields applicable to gliomas? A literature review of the underlying mechanisms and application of extremely low frequency pulsed electromagnetic fields.

Is extremely low frequency pulsed electromagnetic fields applicable to gliomas? A literature review of the underlying mechanisms and application of extremely low frequency pulsed electromagnetic fields.

Journal: Cancer medicine

Published: March 22, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026